Literature DB >> 827758

Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.

L F Gram, P B Andreasen, K F Overo, J Christiansen.   

Abstract

The single dose kinetics of imipramine (IP), nortriptyline (NT), and antipyrine (AP) were compared in 7 healthy subjects. Test doses of AP were given intravenously and test doses of IP and NT were given both orally and by intravenous infusion. The plasma concentration/time curves after intravenous IP and NT were analysed according to a 2-compartment open model. In addition a blood flow independent 'true' clearance was calculated according to a sinusoidal perfusion model. Indirect estimates of hepatic blood flow were obtained from the oral and i.v. plasma concentration/time curves after NT administration. Compared to NT, IP had statistically significant higher clearances, shorter half-lives, and smaller apparent volumes of distribution. There was a significant correlation between apparent volume of distribution (Vdbeta) of IP and NT (n = 5, r = 0.85), but only a weak correlation between the clearance measurements of the two compounds. Systemic clearance of AP and IP showed some positive correlation (n = 7, r = 0.73), whereas there were no significant correlations between AP and NT kinetics. The data indicate that inter- and intraindividual variations in hepatic blood flow may influence the measurements. Other possible sources of variability are individual differences in hepatic extraction kinetics, and differences in binding to blood constituents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 827758     DOI: 10.1007/BF00634149

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Proceedings: Presystemic hepatic elimination.

Authors:  G R Wilkinson; D G Shand
Journal:  Acta Pharm Suec       Date:  1974-12

2.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  Hepatic elimination kinetics: the influence of hepatic blood flow on clearance determination.

Authors:  S Keiding
Journal:  Scand J Clin Lab Invest       Date:  1976-03       Impact factor: 1.713

4.  Genetic control of dicumarol levels in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

5.  Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital-treated rats.

Authors:  C von Bahr
Journal:  Xenobiotica       Date:  1972-05       Impact factor: 1.908

6.  Spectral studies on the interaction of imipramine and some of its oxidized metabolites with rat liver microsomes.

Authors:  C von Bahr; S Orrenius
Journal:  Xenobiotica       Date:  1971-01       Impact factor: 1.908

7.  Individual differences in the plasma half-lives of lipid soluble drugs in man.

Authors:  D S Davies; S S Thorgeirsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

8.  Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

Authors:  A Nagy; L Treiber
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

9.  Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors:  S E Smith; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

10.  Plasma levels and antidepressive effect of imipramine.

Authors:  L F Gram; N Reisby; I Ibsen; A Nagy; S J Dencker; P Bech; G O Petersen; J Christiansen
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

View more
  14 in total

Review 1.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Steady-state kinetics of imipramine in patients.

Authors:  L F Gram; I Sondergaard; J Christiansen; G O Petersen; P Bech; N Reisby; I Ibsen; J Ortmann; A Nagy; S J Dencker; O Jacobsen; O Krautwald
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

4.  Influence of age on mianserin pharmacokinetics.

Authors:  A C Altamura; T Melorio; G Invernizzi; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  The analysis and disposition of imipramine and its active metabolites in man.

Authors:  T A Sutfin; C L DeVane; W J Jusko
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Assessment of the anticholinergic effects of antidepressants in a single-dose cross-over study of salivation and plasma levels.

Authors:  L Clemmesen; P L Mikkelsen; H Lund; T G Bolwig; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Preliminary studies of the kinetics of citalopram in man.

Authors:  K F Overø
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

8.  Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.

Authors:  A C Altamura; T Melorio; G Invernizzi; F Colacurcio; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 9.  Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison.

Authors:  A el-Yazigi; K Chaleby
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Amitriptyline pharmacokinetics. A crossover study with single doses of amitriptyline and nortriptyline.

Authors:  J E Burch; R P Hullin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.